1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow John Rieth: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma Cabozantinib, Pembrolizumab - Advanced Metastatic Melanoma | Phase 1 / Phase 2 | Terminated | John Rieth | 28 | 2019-08-27 | 2026-01-29 |
cabozantinib (1) · pembrolizumab (1)
United States (1)